Normal
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 program1
oral micronized progesterone suspensionPhase 11 trial
Active Trials
Harmony BiosciencesPLYMOUTH MEETING, PA
1 program18 Test Products along with positive and negative controlN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesoral micronized progesterone suspension
Harmony Biosciences18 Test Products along with positive and negative control
OptosP200TE
Clinical Trials (3)
Total enrollment: 236 patients across 3 trials
Determining How Quickly Progesterone Slows LH Pulse Frequency
Start: Nov 2007Est. completion: Jan 202085 patients
Phase 1Completed
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
Start: Aug 2025Est. completion: Sep 202526 patients
N/ANot Yet Recruiting
P200TE and Predicate Agreement and Precision Study
Start: Nov 2022Est. completion: Mar 2023125 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.